CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. High bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in number of surgeries
3.4.1.2. Technological advancements in surgical drapes
3.4.1.3. Growth in government initiatives for infection prevention and control
3.4.2. Restraints
3.4.2.1. Competition among the key players
3.4.2.2. Product recalls
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
CHAPTER 4: SURGICAL DRAPES MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Reusable
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Disposable
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: SURGICAL DRAPES MARKET, BY RISK TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Moderate (AAMI Level 3)
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. High (AAMI Level 4)
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: SURGICAL DRAPES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory Surgical Centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: SURGICAL DRAPES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Risk Type
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Type
7.2.5.1.2. Market size and forecast, by Risk Type
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Type
7.2.5.2.2. Market size and forecast, by Risk Type
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Type
7.2.5.3.2. Market size and forecast, by Risk Type
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Risk Type
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Type
7.3.5.1.2. Market size and forecast, by Risk Type
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Type
7.3.5.2.2. Market size and forecast, by Risk Type
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Type
7.3.5.3.2. Market size and forecast, by Risk Type
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Type
7.3.5.4.2. Market size and forecast, by Risk Type
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Type
7.3.5.5.2. Market size and forecast, by Risk Type
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Type
7.3.5.6.2. Market size and forecast, by Risk Type
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Risk Type
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Type
7.4.5.1.2. Market size and forecast, by Risk Type
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Type
7.4.5.2.2. Market size and forecast, by Risk Type
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Type
7.4.5.3.2. Market size and forecast, by Risk Type
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Type
7.4.5.4.2. Market size and forecast, by Risk Type
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Type
7.4.5.5.2. Market size and forecast, by Risk Type
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Type
7.4.5.6.2. Market size and forecast, by Risk Type
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Risk Type
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Type
7.5.5.1.2. Market size and forecast, by Risk Type
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. South Africa,
7.5.5.2.1. Market size and forecast, by Type
7.5.5.2.2. Market size and forecast, by Risk Type
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. Saudi Arabia
7.5.5.3.1. Market size and forecast, by Type
7.5.5.3.2. Market size and forecast, by Risk Type
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Type
7.5.5.4.2. Market size and forecast, by Risk Type
7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Molnlycke Health Care AB
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Paul Hartmann AG
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Narang Medical Limited
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.4. Standard Textile Co., Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Delta Med SpA
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Medline Industries Inc.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Priontex
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Medica Europe BV
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Cardinal Health
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. 3M Company
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
TABLE 01. GLOBAL SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. SURGICAL DRAPES MARKET FOR REUSABLE, BY REGION, 2022-2032 ($MILLION)
TABLE 03. SURGICAL DRAPES MARKET FOR DISPOSABLE, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 05. SURGICAL DRAPES MARKET FOR MODERATE (AAMI LEVEL 3), BY REGION, 2022-2032 ($MILLION)
TABLE 06. SURGICAL DRAPES MARKET FOR HIGH (AAMI LEVEL 4), BY REGION, 2022-2032 ($MILLION)
TABLE 07. SURGICAL DRAPES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 09. SURGICAL DRAPES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. SURGICAL DRAPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. SURGICAL DRAPES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. SURGICAL DRAPES MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 13. NORTH AMERICA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA SURGICAL DRAPES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 17. U.S. SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 18. U.S. SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 19. U.S. SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. CANADA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 21. CANADA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 22. CANADA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. MEXICO SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 24. MEXICO SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 25. MEXICO SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. EUROPE SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 27. EUROPE SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 28. EUROPE SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE SURGICAL DRAPES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 30. GERMANY SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 31. GERMANY SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 32. GERMANY SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 33. FRANCE SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 34. FRANCE SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 35. FRANCE SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. UK SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 37. UK SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 38. UK SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. ITALY SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 40. ITALY SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 41. ITALY SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. SPAIN SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 43. SPAIN SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 44. SPAIN SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. REST OF EUROPE SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 46. REST OF EUROPE SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. ASIA-PACIFIC SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 49. ASIA-PACIFIC SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC SURGICAL DRAPES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 52. JAPAN SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 53. JAPAN SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 54. JAPAN SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 55. CHINA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 56. CHINA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 57. CHINA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. INDIA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 59. INDIA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 60. INDIA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. AUSTRALIA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. SOUTH KOREA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 65. SOUTH KOREA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. LAMEA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 71. LAMEA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 72. LAMEA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. LAMEA SURGICAL DRAPES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 74. BRAZIL SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 75. BRAZIL SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 76. BRAZIL SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 77. SOUTH AFRICA, SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 78. SOUTH AFRICA, SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 79. SOUTH AFRICA, SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. SAUDI ARABIA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. REST OF LAMEA SURGICAL DRAPES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 84. REST OF LAMEA SURGICAL DRAPES MARKET, BY RISK TYPE, 2022-2032 ($MILLION)
TABLE 85. REST OF LAMEA SURGICAL DRAPES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. MOLNLYCKE HEALTH CARE AB: KEY EXECUTIVES
TABLE 87. MOLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT
TABLE 88. MOLNLYCKE HEALTH CARE AB: PRODUCT SEGMENTS
TABLE 89. MOLNLYCKE HEALTH CARE AB: PRODUCT PORTFOLIO
TABLE 90. PAUL HARTMANN AG: KEY EXECUTIVES
TABLE 91. PAUL HARTMANN AG: COMPANY SNAPSHOT
TABLE 92. PAUL HARTMANN AG: PRODUCT SEGMENTS
TABLE 93. PAUL HARTMANN AG: PRODUCT PORTFOLIO
TABLE 94. NARANG MEDICAL LIMITED: KEY EXECUTIVES
TABLE 95. NARANG MEDICAL LIMITED: COMPANY SNAPSHOT
TABLE 96. NARANG MEDICAL LIMITED: PRODUCT SEGMENTS
TABLE 97. NARANG MEDICAL LIMITED: PRODUCT PORTFOLIO
TABLE 98. STANDARD TEXTILE CO., INC.: KEY EXECUTIVES
TABLE 99. STANDARD TEXTILE CO., INC.: COMPANY SNAPSHOT
TABLE 100. STANDARD TEXTILE CO., INC.: PRODUCT SEGMENTS
TABLE 101. STANDARD TEXTILE CO., INC.: PRODUCT PORTFOLIO
TABLE 102. DELTA MED SPA: KEY EXECUTIVES
TABLE 103. DELTA MED SPA: COMPANY SNAPSHOT
TABLE 104. DELTA MED SPA: PRODUCT SEGMENTS
TABLE 105. DELTA MED SPA: PRODUCT PORTFOLIO
TABLE 106. MEDLINE INDUSTRIES INC.: KEY EXECUTIVES
TABLE 107. MEDLINE INDUSTRIES INC.: COMPANY SNAPSHOT
TABLE 108. MEDLINE INDUSTRIES INC.: PRODUCT SEGMENTS
TABLE 109. MEDLINE INDUSTRIES INC.: PRODUCT PORTFOLIO
TABLE 110. PRIONTEX: KEY EXECUTIVES
TABLE 111. PRIONTEX: COMPANY SNAPSHOT
TABLE 112. PRIONTEX: PRODUCT SEGMENTS
TABLE 113. PRIONTEX: PRODUCT PORTFOLIO
TABLE 114. MEDICA EUROPE BV: KEY EXECUTIVES
TABLE 115. MEDICA EUROPE BV: COMPANY SNAPSHOT
TABLE 116. MEDICA EUROPE BV: PRODUCT SEGMENTS
TABLE 117. MEDICA EUROPE BV: PRODUCT PORTFOLIO
TABLE 118. CARDINAL HEALTH: KEY EXECUTIVES
TABLE 119. CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 120. CARDINAL HEALTH: PRODUCT SEGMENTS
TABLE 121. CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 122. CARDINAL HEALTH: KEY STRATERGIES
TABLE 123. 3M COMPANY: KEY EXECUTIVES
TABLE 124. 3M COMPANY: COMPANY SNAPSHOT
TABLE 125. 3M COMPANY: PRODUCT SEGMENTS
TABLE 126. 3M COMPANY: PRODUCT PORTFOLIO
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
